AXGN
AxoGen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$48.24
+2.43%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
83.1x
EV/EBITDA
−170.5x
Market Cap
$2.59B
MomentumView details →
1D Return
+2.43%
YTD Return
+45.05%
RSI (14)
48.9
ValuationView details →
P/E (Fwd)
83.1x
EV/EBITDA
−170.5x
Market Cap
$2.59B
RSI (14)
48.9
MomentumView details →
1D Return
+2.43%
YTD Return
+45.05%
SummaryUpdated Jun 1, 2026
AxoGen, Inc. (NASDAQ:AXGN) is a medical device company founded in 1986 and headquartered in Alachua, Florida. The company specializes in developing and marketing surgical solutions for peripheral nerve repair and reconstruction. AxoGen has evolved from its early days to become a leading provider of biologically-based nerve repair products, serving surgeons across multiple specialties including plastic reconstruction, orthopedic hand surgery, and oral and maxillofacial surgery. The company operates primarily in the United States but has expanded internationally to Canada, Germany, the United Kingdom, South Korea, and other markets.
Similar companies
Latest newsMore news →